Previous close | 4.4000 |
Open | 4.3000 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 4.3000 - 4.5250 |
52-week range | 3.8500 - 9.5000 |
Volume | |
Avg. volume | 384,744 |
Market cap | 5.876M |
Beta (5Y monthly) | -0.09 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings date | 26 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
LONDON, UK / ACCESSWIRE / February 6, 2024 / Roquefort Therapeutics (LSE:ROQ)(OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market, provides an update ...